Literature DB >> 3546361

Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans.

R C Matthews, J P Burnie, S Tabaqchali.   

Abstract

Candidal antigens were isolated by affinity chromatography from the sera of patients with disseminated Candida albicans infections. The immunodominant 47-kilodalton (kDa) antigen appeared to be a heat-stable breakdown product of several larger heat-labile components (84 to 92, 74 to 79, and 66 to 72 kDa). It was undetectable in normal sera and sera from four patients with systemic C. parapsilosis, C. tropicalis, and C. krusei infections. Serum samples from 92 patients with proven systemic C. albicans infections were examined by the immunoblot technique. Seventy-four patients had detectable antibody, and 92% of these produced antibody to the 47-kDa antigen. All survivors had major serological responses to this antigen, whereas patients who died had no, minor, or fading responses. Fifty-five of the patients were neutropenic following cytotoxic chemotherapy for malignancies, usually lymphoproliferative disorders (hematological patients). The remainder were surgical or medical patients (nonhematological). Hematological patients differed from nonhematological patients in the range of antigens that were commonly recognized by their immune systems, although antibodies to the 47- and 60-kDa antigens were frequently present in both groups. They also differed in that they produced mainly an immunoglobulin M (IgM) response, failing to seroconvent to IgG. This did not reduce survival rates, which were similar in both groups. It may be responsible, however, for the lower antigen titers that were observed in hematological patients when measured by reverse passive latex agglutination.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3546361      PMCID: PMC265873          DOI: 10.1128/jcm.25.2.230-237.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Immunoblot analyses of Candida albicans-associated antigens and antibodies in human sera.

Authors:  M Manning-Zweerink; C S Maloney; T G Mitchell; H Weston
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

2.  Detection of Candida antigen in sera of patients with candidiasis by an enzyme-linked immunosorbent assay-inhibition technique.

Authors:  E Segal; R A Berg; P A Pizzo; J E Bennett
Journal:  J Clin Microbiol       Date:  1979-07       Impact factor: 5.948

3.  Immunoblot analysis of the serological response in systemic candidosis.

Authors:  R C Matthews; J P Burnie; S Tabaqchali
Journal:  Lancet       Date:  1984-12-22       Impact factor: 79.321

Review 4.  Immunoblotting and dot immunobinding--current status and outlook.

Authors:  H Towbin; J Gordon
Journal:  J Immunol Methods       Date:  1984-09-04       Impact factor: 2.303

5.  Circulating immune complexes in patients with Candida albicans infections.

Authors:  G Burges; H P Holley; G Virella
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

6.  Production and characterization of three monoclonal antibodies to Candida albicans proteins.

Authors:  N A Strockbine; M T Largen; H R Buckley
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

7.  Identification and molecular weight characterization of antigens from Candida albicans that are recognized by human sera.

Authors:  N A Strockbine; M T Largen; S M Zweibel; H R Buckley
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

8.  Latex agglutination test for detection of Candida antigen in patients with disseminated disease.

Authors:  L O Gentry; I D Wilkinson; A S Lea; M F Price
Journal:  Eur J Clin Microbiol       Date:  1983-04       Impact factor: 3.267

9.  Diagnostic value of the enzyme-linked immunosorbent assay for detection of Candida albicans cytoplasmic antigen in sera of cancer patients.

Authors:  G F Araj; R L Hopfer; S Chesnut; V Fainstein; G P Bodey
Journal:  J Clin Microbiol       Date:  1982-07       Impact factor: 5.948

10.  Purification and characterization of a major cytoplasmic antigen of Candida albicans.

Authors:  R A Greenfield; J M Jones
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

View more
  43 in total

Review 1.  Heat shock proteins in immune reactions.

Authors:  E Weigl; P Kopecek; M Raska; S Hradilová
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

Review 2.  Diagnosing fungal infections in immunocompromised hosts.

Authors:  C M Tang; J Cohen
Journal:  J Clin Pathol       Date:  1992-01       Impact factor: 3.411

3.  Detection of an antibody response in immunocompetent patients with systemic candidiasis or Candida albicans colonisation.

Authors:  J C Porsius; H J van Vliet; J H van Zeijl; W H Goessens; M F Michel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-05       Impact factor: 3.267

Review 4.  Cell wall and secreted proteins of Candida albicans: identification, function, and expression.

Authors:  W L Chaffin; J L López-Ribot; M Casanova; D Gozalbo; J P Martínez
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

5.  Semiquantitative polymerase chain reaction enzyme immunoassay for diagnosis of disseminated candidiasis.

Authors:  J P Burnie; N Golbang; R C Matthews
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-05       Impact factor: 3.267

6.  Detection of the 43,000-molecular-weight glycoprotein in sera of patients with paracoccidioidomycosis.

Authors:  M J Mendes-Giannini; J P Bueno; M A Shikanai-Yasuda; A W Ferreira; A Masuda
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

7.  Detection of Candida antigenuria in disseminated candidiasis by immunoblotting.

Authors:  R P Ferreira; B Yu; Y Niki; D Armstrong
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

8.  Identification of Candida albicans antigens reactive with immunoglobulin E antibody of human sera.

Authors:  A Ishiguro; M Homma; S Torii; K Tanaka
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Evaluation of enzyme immunoassay for Candida cytoplasmic antigens in neutropenic cancer patients.

Authors:  M Morhart; R Rennie; B Ziola; E Bow; T J Louie
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

10.  Glycolytic enzymes of Candida albicans are nonubiquitous immunogens during candidiasis.

Authors:  R K Swoboda; G Bertram; H Hollander; D Greenspan; J S Greenspan; N A Gow; G W Gooday; A J Brown
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.